AG
RXII

Aperio Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Aperio Group’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-13,671
Closed -$22K – 2083
2015
Q3 		$22K Buy
+13,671
New +$22K ﹤0.01% 1922
2014
Q4 		– Sell
-10,125
Closed -$21K – 1965
2014
Q3 		$21K Sell
10,125
-1,119
-10% -$2.32K ﹤0.01% 1737
2014
Q2 		$34K Sell
11,244
-457
-4% -$1.38K ﹤0.01% 1720
2014
Q1 		$29K Buy
+11,701
New +$29K ﹤0.01% 2024
2013
Q4 		– Hold
0
– – – 1947

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Aperio Group's RXII Position: Q4 2015 in Review

Aperio Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2015, closing a stake of 13,671 shares — an estimated $22K sold.

Aperio Group first reported a position in RXII in Q1 2014 and held it in 4 quarters. The position peaked at $34K in Q2 2014. 83 funds tracked by Wall St. Rank hold RXII as of Q4 2015.

  • Aperio Group reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2015 after selling out during the quarter.
  • Aperio Group sold 13,671 GALENA BIOPHARMA INC COM shares in Q4 2015, an estimated $22K.
  • Aperio Group first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 4 quarters.
  • Aperio Group's GALENA BIOPHARMA INC COM position peaked at $34K in Q2 2014.
  • 83 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2015.

Based on Aperio Group's 13F filing for Q4 2015, filed 21 Jan 2016.